Evidence map›Paper›PMID 39564883›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Integrated Transcriptome Analysis Reveals Novel Molecular Signatures for Schizophrenia Characterization.

Tong Ni, Yu Sun, Zefeng Li, Tao Tan, Wei Han, Miao Li, Li Zhu, Jing Xiao, Huiying Wang, Wenpei Zhang and 10 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tong NiKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Yu SunDepartment of Endocrinology and Metabolism, Qilu Hospital of Shandong University, Ji'nan, 250000, China.
Zefeng LiKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Tao TanOujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, 325603, China.
Wei HanKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Miao LiDepartment of Ultrasound, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, China.
Li ZhuKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Jing XiaoKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Huiying WangKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Wenpei ZhangKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Yitian MaKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Biao WangDepartment of Immunology and Pathogenic Biology, College of Basic Medicine, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Di WenCollege of Forensic Medicine, Hebei Key Laboratory of Forensic Medicine, Hebei Medical University, Shijiazhuang, 050017, China.
Teng ChenKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Justin TubbsDepartment of Psychiatry, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, 999077, China.
Xiaofeng ZengDepartment of Forensic Medicine, School of Forensic Medicine, Kunming Medical University, Kunming, 650500, China.
Jiangwei YanDepartment of Genetics, School of Medicine & Forensics, Shanxi Medical University, Taiyuan, 030009, China.
Hongsheng GuiBehavioral Health Services and Psychiatry Research, Henry Ford Health, Detroit, MI, 48202, USA.
Pak ShamDepartment of Psychiatry, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, 999077, China.
Fanglin GuanKey Laboratory of National Health Commission for Forensic Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.ORCID 0000-0001-5135-3277

Funding

Fundamental Research Funds for the Central Universities XTR052023009Mentored Scientist Grant in Henry Ford Health A20067Natural Science Foundation of China 82030058Natural Science Foundation of China 82171873Natural Science Foundation of China 82222031Natural Science Foundation of China 82293650Natural Science Foundation of China 82293651Oujiang Laboratory OJQD2022002Shaanxi Provincial Science and Technology Innovation Team Project 2024RS-CXTD-80Wenzhou Science and Technology Projects 2023ZM006
6 · The paper itself

Abstract

Schizophrenia (SCZ) is a complex psychiatric disorder presenting challenges for characterization. The current study aimed to identify and evaluate disease-responsive essential genes (DREGs) to enhance the molecular characterization of SCZ. RNA-sequencing data from PsychENCODE (536 SCZ patients, 832 controls) and peripheral blood transcriptome data from 144 recruited subjects (59 SCZ patients, 6 non-SCZ psychiatric patients, 79 controls) are analyzed. Shared differential expression genes are obtained using three algorithms. Support vector machine (SVM)-based recursive feature elimination is employed to identify DREGs. The biological relevance of these DREGs is examined through protein-protein interaction network, pathway enrichment, polygenic scoring, and brain tissue expression. Key DREGs are validated in SCZ animal models. A DREGs-based machine-learning model for SCZ characterization is developed and its performance is assessed using multiple datasets. The analysis identified 184 DREGs forming an interconnected network involved in synaptic plasticity, inflammation, neuronal development, and neurotransmission. DREGs exhibited distinct expression in SCZ-related brain regions and animal models. Their genetic contributions are comparable to genome-wide polygenic risk scores. The DREG-based SVM model demonstrated high performance (AUC 85% for SCZ characterization, 79% for specificity). These findings provide new insights into the molecular mechanisms underlying SCZ and emphasize the potential of DREGs in improving SCZ characterization.

Indexed as

Gene Expression ProfilingSchizophreniaTranscriptomeAdultAnimalsBrainDisease Models, AnimalFemaleHumansMaleMiddle AgedSupport Vector Machinecharacterizationmachine learningmolecular signaturesschizophreniatranscriptome

Identifiers

PMID39564883
PMCPMC11727269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.